Omega-3 Fatty Acid Status Biomarkers: Analytical Validity, Clinical Utility, and Public Health Applications – A Narrative Review
DOI:
https://doi.org/10.14738/bjhr.1305.12176Keywords:
Omega-3 Index, EPA, DHA, biomarkers, personalised nutrition, omega-6: omega-3 ratio, dried blood spot testing, public health, precision nutritionAbstract
Omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid and docosahexaenoic acid, are essential to cardiovascular, neurological, metabolic, and immune function. Despite substantial evidence supporting their biological importance, intake remains inadequate in many populations worldwide. Because dietary assessment methods are limited by recall bias, reporting error, and variation in food composition, objective biomarkers are increasingly used to assess physiological omega-3 status. This narrative review examines the scientific basis, analytical validity, clinical relevance, and public health applications of the principal omega-3 biomarkers, with emphasis on the Omega-3 Index, the omega-6:omega-3 ratio, and dried blood spot testing. The Omega-3 Index, based on red blood cell EPA and DHA content, emerges as the most robust marker of long-term omega-3 status and the one most consistently associated with clinically relevant outcomes, particularly in cardiovascular health. The omega-6:omega-3 ratio offers complementary insight into dietary balance and inflammatory context, although its interpretive limitations reduce its value as a stand-alone marker. Dried blood spot testing has broadened access to fatty acid assessment by enabling minimally invasive, scalable sampling suitable for both clinical and population-level use. Together, these biomarkers support a shift toward more objective, individualised, and prevention-orientated approaches to nutrition assessment. Their wider integration into healthcare and public health practice may improve risk stratification, guide intervention, and strengthen population monitoring of omega-3 sufficiency.
References
Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469-484.
Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3(1):1-7.
Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137(4):855-859.
Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645-662.
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365-379.
Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res. 2016;63:132-152.
Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133(3):925S-932S.
Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet. 2009;125(5-6):507-525.
Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348-380.
Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab. 2012;2012:539426.
von Schacky C. Assessing omega-3 fatty acids – critically weighing options and relevance. J Clin Lipidol. 2024;Nov.
Dragsted LO. Relying on biomarkers for intake assessment in nutrition. Am J Clin Nutr.
Jackson PA, Husberg C, Hustvedt SO, Calder PC, Khan J, Avery H, et al. Diurnal rhythm of plasma EPA and DHA in healthy adults. Prostaglandins Leukot Essent Fatty Acids. 2020;154:102054.
Marangoni F, Colombo C, Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem. 2004;326(2):267-272.
Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a doseresponse randomized controlled trial. J Am Heart Assoc. 2013;2(6):e000513.
Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220.
Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: estimation from 10 cohort studies. Atherosclerosis. 2017;262:51-54.
Dempsey M, Rockwell MS, Wentz LM. The influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: a scoping review. Front Nutr. 2023;10:1072653. Scholar Publishing
Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease. J Am Coll Cardiol.
Del Gobbo LC, Imamura F, Aslibekyan S, Marklund M, Virtanen JK, Wennberg M, et al. ω-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern Med. 2016;176(8):1155-1166.
Ren J, Chung SH. Anti-inflammatory effect of α-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NF-κB and mitogen-activated protein kinase pathways. J Agric Food Chem.
Deshmukh GV, Niaz H, Bai R, Kim DH, Kim JW, Asghar J, et al. The role of omega-3 fatty acid supplementation in slowing cognitive decline among elderly patients with Alzheimer's disease: a systematic review of randomized controlled trials. Cureus. 2024;Nov.
Akinkuolie AO, Ngwa JS, Meigs JB, Djoussé L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomised controlled trials. Clin Nutr. 2011;30(6):702-707.
Nording ML, Yang J, Georgi K, Hegedus Karbowski C, German JB, Weiss RH, et al. Individual variation in lipidomic profiles of healthy subjects in response to omega-3 fatty acids. PLoS One. 2013;8(10):e76575.
Harris WS. Recent studies confirm the utility of the omega-3 index. Curr Opin Clin Nutr Metab Care. 2024;28(2):91.
Klingler M, Koletzko B. Novel methodologies for assessing omega-3 fatty acid status – a systematic review. Br J Nutr. 2012;107(S2):S53-S63.
Silva V, Barazzoni R, Singer P. Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans. Nutr Clin Pract. 2014;29(1):63-72.
Dicklin MR, Anthony JC, Winters BL, Maki KC. ω-3 polyunsaturated fatty acid status testing in humans: a narrative review of commercially available options. J Nutr. 2024;Mar:S0022-3166(24)00164-0.
McBurney MI, Tintle NL, Vasan RS, Sala-Vila A, Harris WS. Using an erythrocyte fatty acid fingerprint to predict risk of all-cause mortality: the Framingham Offspring Cohort. Am J Clin Nutr. 2021;114(4):1447-1454.
Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement.
Cederholm T, Salem N, Palmblad J. ω-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr. 2013;4(6):672-676.
Bo Y, Zhang X, Wang Y, You J, Cui H, Zhu Y, et al. The n-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: a double-blind randomized controlled trial. Nutrients. 2017;9(1):54.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature.
Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. 2012;53(12):2525-2545.
Gutierres D, Pacheco R, Reis CP. The role of omega-3 and omega-6 polyunsaturated fatty acid supplementation in human health. Foods. 2025;14(19):3299. Scholar Publishing
Garcia-Urtiaga L, Cano A, Caro M, Pagaldai J, Amezaga J, Tueros I, et al. Dried blood spot technique for dietary fat assessment in a human nutritional intervention focused on oily fish intake. Nutr Metab (Lond). 2025;22(1):89.
Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018;361:k2173.
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079-1094.
Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006;83(6):1483S-1493S.
Baylin A, Kabagambe EK, Siles X, Campos H. Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr. 2002;76(4):750-757.
Torrissen M, Gisslevik E, Gundersen TE, Bolstad T, Eide O, Rizzo AM, et al. Global variations in omega-3 fatty acid status and omega-6:omega-3 ratios: insights from >500,000 whole-blood dried blood spot samples. Lipids Health Dis. 2025;24(1).
Picó C, Serra F, Rodríguez AM, Keijer J, Palou A. Biomarkers of nutrition and health: new tools for new approaches. Nutrients. 2019;11(5):1092.
Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85(6):1457-1464.
Bailey-Hall E, Nelson EB, Ryan AS. Validation of a rapid measure of blood PUFA levels in humans. Lipids. 2007;43(2):181-186.
Naska A, Lagiou A, Lagiou P. Dietary assessment methods in epidemiological research: current state of the art and future prospects. F1000Res. 2017;6:926.
Harris WS. Assessing fatty acid biostatus: red blood cells or plasma? Lipid Technol.
Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomarkers: a systematic review of randomised clinical trials. Br J Nutr. 2012;107(S2):S159-S170.
Fisk HL, Shaikh SR. Emerging mechanisms of organ crosstalk: the role of oxylipins. Nutr Bull.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 John Bolodeoku, Terry Gbaa, Wycliffe Mbagaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
